$33,715,767
Department of Health and Human Services·National Institutes of Health
biotechactive
WORK BEGAN2021-01-28·LATEST ACTION—·SOURCEUSASPENDING·SOURCE IDASST_NON_UM1AI151958_075
Award description
AIRWAY TRANSCRIPTOMIC RESPONSES TO COVID-19 ILLNESSES IN THE HUMAN EPIDEMIOLOGY AND RESPONSE TO SARS-COV-2 (HEROS) COHORT
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
The Buildout's read
What the model surfaced from this award
Confidence: medium
In plain English
Research into genetic responses to COVID-19 infection in a large human epidemiological cohort that began in 2021.
Sub-sectors
genomicscovid-19-researchepidemiology
Why this matters
Identifies genetic factors in COVID-19 response to improve treatment development and inform pandemic preparedness strategies.
Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-16. Cost: $0.031633.
Period of performance
Start
2021-01-28
End
2027-03-31
Status
activein 259 days
Sources
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier ASST_NON_UM1AI151958_075.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.